BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients
/PRNewswire/ -- Biofluidica today announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive...
Source: prnewswire.com